Full-Time

Professional Aesthetic Consultant

Multiple Teams

Posted on 10/7/2025

Revance

Revance

501-1,000 employees

Biotech aesthetics company: neuromodulators and fillers

Compensation Overview

$95k - $105k/yr

+ Incentive Compensation

Frisco, TX, USA + 1 more

More locations: Plano, TX, USA

In Person

Category
Sales & Account Management (1)
Required Skills
Sales
Lead Generation
Requirements
  • Master’s degree or Bachelor’s degree
  • Minimum 2 years of outside sales experience in the Medical or Aesthetics industry
Responsibilities
  • Strategically manages the territory to meet or exceed sales objectives.
  • Responsible for lead generation through direct contact with customers in assigned area.
  • Maintains effective customer relations, develops opportunities for growth within an existing customer base, and assures market penetration and profitability while achieving sales forecasts.
  • Delivers sales results per assigned quarterly goals, and have primary responsibility for area metrics, issues and customers.
  • Maintains a pipeline of opportunities to meet or exceed sales objectives.
  • Provides and filters key market insights back to sales and marketing management.
  • Maintains accurate reporting, records and files necessary for proper management of territory.
  • Positively represents Revance throughout customer locations.
  • Actively participates in sales meetings, conference calls, and other necessary business meetings.
  • Demonstrates honesty and integrity while modeling behaviors consistent with company standards, and adheres to all sales policies and procedures.
Desired Qualifications
  • Bachelor’s degree and minimum 2 years of sales experience
  • 5+ years of sales/account management experience a plus
  • History of meeting and exceeding sales objectives.
  • Experience in medical aesthetics, dermatology, or plastic surgery a plus
  • Launch experience.
  • Experience in buy and bill or cash pay medicine a plus
  • Advanced business acumen; understands competitors, influencers and industry trends.
  • Ability to work in a launch or fast-paced, highly visible and dynamic environment.
  • Strong knowledge of analytics, budgeting and key revenue drivers; able to leverage data to target and prioritize opportunities.
  • A valid driver’s license is required

Revance Therapeutics develops neuromodulators and dermal fillers for the premium aesthetics market, with possible therapeutic uses for muscle movement and pain disorders. Its injectable products are used by healthcare professionals to reduce wrinkles and restore facial volume, improving patient outcomes. The company stands apart by pairing a portfolio of cosmetic injectables with HintMD, a fintech platform that streamlines payments and clinic management for aesthetic practices. Its goal is to lead the premium aesthetics space by offering differentiated injectables and expanding fintech-enabled services for practice efficiency.

Company Size

501-1,000

Company Stage

IPO

Headquarters

Nashville, Tennessee

Founded

1999

Simplify Jobs

Simplify's Take

What believers are saying

  • $100 SkinPen rebate drives adoption through June 2026.
  • RHA Collection Mepivacaine launched August 2025 enhances procedures.
  • Nadeem Moiz CEO leads post-Crown integration since October 2025.

What critics are saying

  • Crown acquisition dilutes biotech focus, eroding revenue in 6-12 months.
  • AbbVie QULIPTUO captures DAXXIFY share in 12-18 months.
  • Teoxane terminates RHA distribution in 18-24 months.

What makes Revance unique

  • SkinPen Precision Elite distributed 1M kits since January 2025.
  • RHA Dynamic Volume FDA-approved for natural midface rejuvenation.
  • StriVectin TL Mask leads neck skincare with Alpha-3 Peptide.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Unlimited Paid Time Off

401(k) Company Match

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

1%

2 year growth

-3%
Modern Aesthetics
Mar 31st, 2026
SkinPen milestone highlights growth in microneedling demand.

SkinPen milestone highlights growth in microneedling demand. 03/31/2026 Key Takeaways * Revance reported distributing more than 1 million SkinPen treatment kits since January 2025. * Growth follows the launch of SkinPen Precision Elite and reflects increasing demand for microneedling. * The company introduced a patient rebate program to support continued adoption. Revance announced that it has distributed more than 1 million SkinPen treatment kits nationwide since January 2025, marking a milestone for the company's microneedling portfolio. The achievement comes approximately 1 year after the launch of SkinPen Precision Elite, the latest iteration of the device. SkinPen is positioned as a leading microneedling platform in the United States, with the Precision Elite device designed to enhance consistency and provider control through updated balance and ergonomics. According to the company, the system builds on earlier versions of SkinPen, which are used for mechanical microneedling procedures intended to improve skin appearance with minimal downtime. "Reaching 1 million SkinPen treatment kits sold since January 2025 is a powerful proof point - not only for SkinPen, but for the rapid growth of microneedling as an in-demand aesthetic treatment," said Nadeem Moiz, Chief Executive Officer of Revance. "This momentum reflects our continued commitment to advancing the category through innovation, education, and clinically supported outcomes." To coincide with the milestone, Revance launched the "$100 Reasons to Love SkinPen" rebate program, offering patients $100 off a series of 3 or more treatments between February 1 and June 30, 2026. The company stated that the initiative is intended to support patient access and continued utilization.

PR Newswire
Mar 24th, 2026
Revance and Teoxane launch RHA Dynamic Volume for natural-looking midface rejuvenation

Revance and Teoxane have announced the US availability of RHA Dynamic Volume, a hyaluronic acid dermal filler approved by the FDA for cheek augmentation and age-related midface contour deficiencies in adults aged 22 years or older. The product, formerly known as RHA 4 Mepi, is designed to address volume loss in both dynamic superficial fat and static deep fat, delivering results lasting up to one year. Clinical studies showed approximately 98% of patients reported natural-looking results at two months, whilst over 94% reported natural-feeling results at rest and in motion at one year. RHA Dynamic Volume uses Teoxane's unique rheology to adapt to facial movements. The launch responds to growing demand for natural-looking facial rejuvenation treatments, particularly amongst patients experiencing volume loss from weight loss medications or ageing.

PR Newswire
Feb 26th, 2026
StriVectin launches Barrier Restore+ collection for sensitive skin with fragrance-free ceramide cream and milky mist

Revance has launched StriVectin's Barrier Restore+ Collection, the brand's first fragrance-free line for sensitive skin. The debut includes two products: the Barrier Restore+ Soothing Ceramide Cream (£69) and Barrier Restore+ Soothing Milky Mist (£39). Both products feature a new Turmeric-146 Peptide and StriVectin's NIA-114, an optimised form of Niacin clinically proven to strengthen the skin barrier. The ceramide cream is hypoallergenic and has received the National Rosacea Society's Seal of Acceptance. In clinical testing, 90% of users reported immediate cooling and refreshment. The collection is available at Ulta stores, Ulta.com, Amazon, and StriVectin's website. StriVectin is backed by over 35 years of clinical research in skin longevity.

PR Newswire
Jan 27th, 2026
Revance Executives to Present at IMCAS World Congress 2026

Revance executives to present at IMCAS World Congress 2026. News provided by. Jan 27, 2026, 16:05 ET NASHVILLE, Tenn., Jan. 27, 2026 /PRNewswire/ - Revance, a fast-growing global leader in aesthetics and skincare, today announced its participation in the 2026 International Master Course on Aging Science (IMCAS) World Congress, which will be held in Paris at the Palais de Congrès de Paris from January 29-31, 2026. The IMCAS World Congress is one of the most highly anticipated events for cutting-edge advancements and scientific excellence. It offers a deep dive into the latest breakthroughs in medical aesthetics, from revolutionary plastic surgery techniques to innovative dermatological treatments. Jeff Bedard, Revance Executive Chairman, will participate in "La Tribune - The Economic Forum," where he will discuss next-gen aesthetics, industry trends, growth and skin health innovation, highlighting his leadership in bringing science and technology to the forefront of aesthetics. Additionally, Conor Gallagher, Ph.D., Revance Chief Science Officer, will participate in a session titled, "Aesthetic Toxins: New Challenges," as well as a roundtable product analysis titled, "Product Analysis: Botulinum Toxin." Revance Sessions at IMCAS: Scheduled times are in local Central European Time (GMT+1hour) * Revance Speaker: Jeff Bedard * Date/Time: Friday, Jan. 30, 2026, 1:30 p.m. to 3:30 p.m. Local Time * Venue: Amphi Havane - Level 3, Palais des Congrès de Paris * Revance Speaker: Conor Gallagher, Ph.D. * Date/Time: Saturday, Jan. 31, 2026, 8:30 a.m. to 10 a.m. Local Time * Venue: Room 151 - Level 1, Palais des Congrès de Paris * Revance Speaker: Conor Gallagher, Ph.D. * Date/Time: Saturday, Jan. 31, 2026, 3:30 p.m. to 5:00 p.m. Local Time * Venue: Room 151 - Level 1, Palais des Congrès de Paris About Revance Revance is a fast-growing global aesthetics and skincare company focused on providing innovative aesthetics and market-leading skincare offerings throughout every stage of life. With a differentiated portfolio of products spanning 60 countries, Revance meets the evolving needs of patients and consumers worldwide through continued innovation and commercialization of new products and treatments. Focused on skin science for life, Revance's extensive portfolio includes leading brands within the aesthetics, consumer skincare, and therapeutics categories. Aesthetics offerings include: DAXXIFY(R)(DaxibotulinumtoxinA-lanm) for injection; the RHA(R) Collection of dermal fillers by Teoxane SA; SkinPen(R), an industry-leading microneedling device; MicroPen EVO(TM), an FDA-cleared microneedling device; ProGen PRP Eclipse, the gold standard in Platelet-Rich Plasma; and Biojuve(R), a clinically proven living microbe technology, among others. Revance's strong consumer skincare portfolio includes brands such as PanOxyl(R), Blue Lizard(R), StriVectin(R), Sarna(R), Zeasorb(R), Desenex(R), and Keri(R). SOURCE Revance

PR Newswire
Dec 9th, 2025
Revance Announces Launch of New StriVectin(R) TL Advanced Sculpting Neck & Jawline Mask

Revance announces launch of new StriVectin(R) TL Advanced Sculpting Neck & Jawline Mask. News provided by. The #1 Skincare Brand for Neck and Décolleté is Expanding its Award-Winning Portfolio[1] NASHVILLE, Tenn., Dec. 9, 2025 /PRNewswire/ - Revance is proud to introduce a new product addition to its StriVectin prestige premium skincare brand - TL Advanced Sculpting Neck & Jawline Mask. StriVectin is the #1 Skincare Brand for Neck and Décolleté.[1] The TL Advanced Sculpting Neck & Jawline Mask is formulated with StriVectin's proprietary Alpha-3 Peptide(R) and is clinically proven to tighten, tone, and depuff the neck and jawline area,[2] with results that improve over time with consistent use.[3] In just 20 minutes, 88% agreed that skin immediately felt firmer[2] and after two weeks of use, subjects reported that facial contours appeared sharpened, and the jawline appeared sharper and more lifted.[3] Engineered with a form-fitting hydrogel design, the innovative mask hugs the natural contours of the neck and jawline to optimize ingredient absorption and provide visible results to areas most prone to the effects of gravity. Perfect as a self-care ritual, it's the ultimate secret for those 'chin-up' moments before any special event. "We are thrilled to bring this latest neck innovation to market. As the leading skincare brand for neck and décolleté, we've set a high bar for what meaningful innovation should look like," said Giovanna Wilk, Vice President, Marketing. "With the TL Advanced Sculpting Neck & Jawline Mask, we focused on every detail, including engineering a custom shape and fit, and pairing it with our cutting-edge ingredients to deliver a clinically proven product we believe consumers will love. It's a perfect addition for our loyal neck cream users looking to expand their regimen and an ideal entry point for those new to dedicated neck care." Formulated with NIA-114(R), Alpha-3 Peptide, and caffeine, the mask helps cool, de-puff, and firm skin while supporting the moisture barrier for a more sculpted, contoured appearance. "StriVectin's unwavering commitment to innovation and science-backed ingredients continues to set the brand apart," said Dr. Mara Weinstein Velez, Board-Certified Dermatologist. "Their advanced, proprietary formulations make StriVectin one of my top recommendations for patients looking to visibly improve the appearance of the neck and jawline." The StriVectin TL Advanced Sculpting Neck & Jawline Mask ($18, 1 count) is currently available at Ulta and on Strivectin.com. It will be available at all retailers, including Amazon and Sephora, starting January 2026. [1] Circana, LLC, US Prestige Beauty Total Department/Specialty, Skincare by Brand, Body Part: Neck/Décolleté, Dollar & Unit Sales, January - December 2024. [2] Based on consumer perception questionnaire on 34 subjects immediately after use as directed. [3] Based on consumer perception questionnaire on 34 subjects after 2 weeks of use as directed. About StriVectin StriVectin is an award-winning prestige clinical skincare brand backed by over 35 years of clinical research in skin longevity. Fueled by its mission to empower women at every stage of their skincare journey, StriVectin delivers advanced, targeted formulas to solve for aging skin's most challenging concerns. As innovators in skin science, all formulas feature StriVectin's proprietary NIA-114 technology. This powerhouse molecule, even more effective than Niacinamide, has been clinically proven to strengthen the skin's barrier, enhance the performance of other ingredients, and help skin act younger and appear more youthful. StriVectin's results are real, visible, and validated by independent clinical studies on every product - it's how we built a winning portfolio. Cruelty-free, paraben-free, and suitable for all skin types. StriVectin products are available through top department stores and specialty retailers across North America, Europe, the Middle East, and Asia. Our corporate headquarters are in Nashville, TN. For more details, visit strivectin.com. About Revance Revance is a fast-growing, highly acquisitive, global aesthetics and skincare company committed to delivering innovative aesthetics and market-leading skincare solutions across every stage of life. With a differentiated portfolio and market position, Revance meets the evolving needs of patients and consumers worldwide through continued innovation and the commercialization of new products and treatments. Focused on skin science for life, Revance continues to expand its global footprint, with distribution spanning 60 countries and a significant opportunity to enter new markets. Revance's balanced portfolio includes innovative products in the aesthetics space such as DAXXIFY(R)(DaxibotulinumtoxinA-lanm) for injection, the RHA(R) Collection of dermal fillers by Teoxane SA, and SkinPen(R), an industry-leading microneedling device. RHA(R) technology is proprietary to and manufactured in Switzerland by Teoxane SA, and Revance is an independent distributor of Teoxane SA to supply the RHA Collection of dermal fillers to the U.S. market. In addition, its consumer skincare portfolio includes leading brands such as PanOxyl(R), Blue Lizard(R), StriVectin(R) and BIOJUVE(R). SOURCE Revance

INACTIVE